Abstract
We report the development of a metastasis-on-a-chip platform to model and track hepatocellular carcinoma (HCC)–bone metastasis and to analyze the inhibitory effect of an herb-based compound, thymoquinone (TQ), in hindering the migration of liver cancer cells into the bone compartment. The bioreactor consisted of two chambers, one accommodating encapsulated HepG2 cells and one bone-mimetic niche containing hydroxyapatite (HAp). Above these chambers, a microporous membrane was placed to resemble the vascular barrier, where medium was circulated over the membrane. It was observed that the liver cancer cells proliferated inside the tumor microtissue and disseminated from the HCC chamber to the circulatory flow and eventually entered the bone chamber. The number of metastatic HepG2 cells to the bone compartment was remarkably higher in the presence of HAp in the hydrogel. TQ was then used as a metastasis-controlling agent in both free form and encapsulated nanoparticles, to analyze its suppressing effect on HCC metastasis. Results indicated that the nanoparticle-encapsulated TQ provided a longer period of inhibitory effect. In summary, HCC–bone metastasis-on-a-chip platform was demonstrated to model certain key aspects of the cancer metastasis process, hence corroborating the potential of enabling investigations on metastasis-associated biology as well as improved anti-metastatic drug screening.
Similar content being viewed by others
Availability of data and material (data transparency)
The datasets that support the findings of this study are available from the corresponding authors upon reasonable request. All requests for raw and analyzed data and materials will be promptly reviewed by the Brigham and Women’s Hospital to verify whether the request is subject to any intellectual property or confidentiality obligations. Any data and materials that can be shared will be released via a Material Transfer Agreement.
References
Society AC (2015) Global cancer facts & figures, 3rd edn. American Cancer Society, Atlanta
Portillo-Lara R, Annabi N (2016) Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment. Lab Chip 16(21):4063–4081
Sharifi F, Firoozabadi B, Firoozbakhsh K (2019) Numerical investigations of hepatic spheroids metabolic reactions in a perfusion bioreactor. Front Bioeng Biotechnol 7:221
Sharifi F, Htwe SS, Righi M, Liu H, Pietralunga A, Yesil-Celiktas O, Maharjan S, Cha BH, Shin SR, Dokmeci MR (2019) A foreign body response-on-a-chip platform. Adv Healthc Mater 8(4):1801425
Kong J, Luo Y, ** D, An F, Zhang W, Liu L, Li J, Fang S, Li X, Yang X (2016) A novel microfluidic model can mimic organ-specific metastasis of circulating tumor cells. Oncotarget 7(48):78421
Ananthakrishnan A, Gogineni V, Saeian K (2006) Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol 23(1):47–63
Katyal S, Oliver JH III, Peterson MS, Ferris JV, Carr BS, Baron RL (2000) Extrahepatic metastases of hepatocellular carcinoma. Radiology 216(3):698–703
Ng J, Shin Y, Chung S (2012) Microfluidic platforms for the study of cancer metastasis. Biomed Eng Lett 2(2):72–77
Skardal A, Shupe T, Atala A (2016) Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling. Drug Discov Today 21(9):1399–1411
Bersini S, Jeon JS, Dubini G, Arrigoni C, Chung S, Charest JL, Moretti M, Kamm RD (2014) A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials 35(8):2454–2461
Bischel LL, Casavant BP, Young PA, Eliceiri KW, Basu HS, Beebe DJ (2014) A microfluidic coculture and multiphoton FAD analysis assay provides insight into the influence of the bone microenvironment on prostate cancer cells. Integr Biol 6(6):627–635
Zuchowska A, Kwapiszewska K, Chudy M, Dybko A, Brzozka Z (2017) Studies of anticancer drug cytotoxicity based on long-term HepG2 spheroid culture in a microfluidic system. Electrophoresis 38(8):1206–1216
Breuksch I, Weinert M, Brenner W (2016) The role of extracellular calcium in bone metastasis. J Bone Oncol 5(3):143–145
Joyce JA, Pollard JW (2009) Microenvironmental regulation of metastasis. Nat Rev Cancer 9(4):239
Khader M, Eckl PM (2014) Thymoquinone: an emerging natural drug with a wide range of medical applications. Iran J Basic Med Sci 17(12):950
Loessner D, Meinert C, Kaemmerer E, Martine LC, Yue K, Levett PA, Klein TJ, Melchels FP, Khademhosseini A, Hutmacher DW (2016) Functionalization, preparation and use of cell-laden gelatin methacryloyl–based hydrogels as modular tissue culture platforms. Nat Protoc 11(4):727
Xavier JR, Thakur T, Desai P, Jaiswal MK, Sears N, Cosgriff-Hernandez E, Kaunas R, Gaharwar AK (2015) Bioactive nanoengineered hydrogels for bone tissue engineering: a growth-factor-free approach. ACS Nano 9(3):3109–3118
Yeh W-C, Li P-C, Jeng Y-M, Hsu H-C, Kuo P-L, Li M-L, Yang P-M, Lee PH (2002) Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol 28(4):467–474
Ma X, Qu X, Zhu W, Li Y-S, Yuan S, Zhang H, Liu J, Wang P, Lai CSE, Zanella F (2016) Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting. Proc Natl Acad Sci 113(8):2206–2211
Olechnowicz SW, Edwards CM (2014) Contributions of the host microenvironment to cancer-induced bone disease. Can Res 74(6):1625–1631
Sinha V, Singla A, Wadhawan S, Kaushik R, Kumria R, Bansal K, Dhawan S (2004) Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274(1):1–33
Karagozlu MZ, Kim S-K (2015) Anti-cancer effects of chitin and Chitosan derivatives. In: Kim S-K (ed) Handbook of anticancer drugs from marine origin. Springer, pp 413–421
Soni P, Kaur J, Tikoo K (2015) Dual drug-loaded paclitaxel–thymoquinone nanoparticles for effective breast cancer therapy. J Nanopart Res 17(1):18
He C, Hu Y, Yin L, Tang C, Yin C (2010) Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31(13):3657–3666
Fan W, Yan W, Xu Z, Ni H (2012) Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B 90:21–27
Hosseini SF, Zandi M, Rezaei M, Farahmandghavi F (2013) Two-step method for encapsulation of oregano essential oil in chitosan nanoparticles: preparation, characterization and in vitro release study. Carbohydr Polym 95(1):50–56
Ganea GM, Fakayode SO, Losso JN, Van Nostrum CF, Sabliov CM, Warner IM (2010) Delivery of phytochemical thymoquinone using molecular micelle modified poly (d, l lactide-co-glycolide)(PLGA) nanoparticles. Nanotechnology 21(28):285104
Abouelmagd SA, Sun B, Chang AC, Ku YJ, Yeo Y (2015) Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right? Mol Pharm 12(3):997–1003
Funding
This work was supported by the National Institutes of Health (K99CA201603, R00CA201603, R21EB025270, R21EB026175, R01EB028143), the New England Anti-Vivisection Society, and the Brigham Research Institute.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Consent to participate
Consent to participate is not applicable in this study.
Consent for publication
All authors have reviewed and approved the manuscript.
Ethics approval
Ethical approval is not applicable in this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Sharifi, F., Yesil-Celiktas, O., Kazan, A. et al. A hepatocellular carcinoma–bone metastasis-on-a-chip model for studying thymoquinone-loaded anticancer nanoparticles. Bio-des. Manuf. 3, 189–202 (2020). https://doi.org/10.1007/s42242-020-00074-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42242-020-00074-8